1. Skip to header
  2. Skip to main
  3. Skip to content
  4. Skip to sidebar
  5. Skip to footer
Posted on Monday, Jan 5, 2009

New Test Available for Mesothelioma Diagnosis

Source: Rosetta Genomics

Rosetta Genomics has recently announced the availability of miRview(TM) meso, a new test for diagnosing mesothelioma that it developed using its proprietary microRNA-based technology. The new test provides precise differentiation between malignant mesothelioma and the various forms of lung cancer by identifying molecular differences between the two cancers. This is an important development for patients with mesothelioma, as the disease is often—mistakenly—described as form of lung cancer, even thought it’s actually quite different and requires different treatment strategies to maximize a patient’s therapeutic potential.

The availability of this new test gives mesothelioma specialists one more tool in their fight against pleural mesothelioma and peritoneal mesothelioma, as well as the disease’s rarest forms.